CACNB2 (NM_000724) Human Recombinant Protein
CAT#: TP761246
Purified recombinant protein of Human calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 1, full length, with N-terminal HIS tag, expressed in E. coli, 50ug
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
A DNA sequence encoding human full-length CACNB2
|
Tag | N-His |
Predicted MW | 68 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 50mM Tris, 8M Urea, pH8.0. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_000715 |
Locus ID | 783 |
UniProt ID | Q08289, Q59H42 |
Cytogenetics | 10p12.33-p12.31 |
Refseq Size | 3721 |
Refseq ORF | 1815 |
Synonyms | CAB2; CACNLB2; CAVB2; MYSB |
Summary | 'This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]' |
Protein Families | Druggable Genome, Ion Channels: Other |
Protein Pathways | Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway |
Documents
FAQs |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC404468 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404469 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404474 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404477 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404479 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC404480 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC424553 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC430887 | CACNB2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY404468 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 7 |
USD 605.00 |
|
LY404469 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 6 |
USD 605.00 |
|
LY404474 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 3 |
USD 605.00 |
|
LY404477 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 5 |
USD 605.00 |
|
LY404479 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 2 |
USD 605.00 |
|
LY404480 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 4 |
USD 605.00 |
|
LY424553 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 1 |
USD 605.00 |
|
LY430887 | Transient overexpression lysate of calcium channel, voltage-dependent, beta 2 subunit (CACNB2), transcript variant 2 |
USD 396.00 |
{0} Product Review(s)
Be the first one to submit a review